Sustained virological response after 4-week ritonavir-boosted paritaprevir, ombitasvir and dasabuvir plus ribavirin treatment in a kidney transplant recipient

Claudio Calvanese; Andrea Lisotti; Saverio Fiorenza; Marcora Mandreoli; Giancarlo Caletti; Pietro Fusaroli

doi:10.15403/jgld.2014.1121.263.frz

Sustained virological response after 4-week ritonavir-boosted paritaprevir, ombitasvir and dasabuvir plus ribavirin treatment in a kidney transplant recipient

Authors

Claudio Calvanese Gastroenterology Unit, Department of Medical and Surgical Sciences University of Bologna, Hospital of Imola, Italy
Andrea Lisotti Gastroenterology Unit, Department of Medical and Surgical Sciences University of Bologna, Hospital of Imola, Italy
Saverio Fiorenza Nephrology Unit, Hospital of Imola, Italy
Marcora Mandreoli Nephrology Unit, Hospital of Imola, Italy
Giancarlo Caletti Gastroenterology Unit, Department of Medical and Surgical Sciences University of Bologna, Hospital of Imola, Italy
Pietro Fusaroli Gastroenterology Unit, Department of Medical and Surgical Sciences University of Bologna, Hospital of Imola, Italy

DOI:

https://doi.org/10.15403/jgld.2014.1121.263.frz

Keywords:

Abstract

Downloads

Published

2017-09-01

How to Cite

Calvanese C, Lisotti A, Fiorenza S, Mandreoli M, Caletti G, Fusaroli P. Sustained virological response after 4-week ritonavir-boosted paritaprevir, ombitasvir and dasabuvir plus ribavirin treatment in a kidney transplant recipient. JGLD [Internet]. 2017 Sep. 1 [cited 2026 Aug. 11];26(3):319-21. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/993